| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/31/1994 | CA2123406A1 Ikaros: a t cell pathway regulatory gene |
| 03/30/1994 | EP0589843A1 Pharmaceutical compositions containing cyclosporins |
| 03/30/1994 | EP0589840A1 Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/30/1994 | EP0589741A1 Use of a direct inhibitor of thrombin for the production of a drug with thrombolytic activity |
| 03/30/1994 | EP0589719A1 Modified platelet factor-4 |
| 03/30/1994 | EP0589378A2 Glycosylated cytokines |
| 03/30/1994 | EP0589181A2 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 03/30/1994 | EP0589037A1 Indian derivative and thromboxane antagonist containing the same |
| 03/30/1994 | EP0588905A1 Radiolabelled somatostatin derivatives, their preparation and use |
| 03/30/1994 | EP0588848A1 Modified sialyl lewis?a compounds |
| 03/30/1994 | EP0588816A1 Transgenic non-human animal carrying a non-infectious hiv genome |
| 03/30/1994 | CN1084409A Pharmaceutical compositions and uses therefor |
| 03/30/1994 | CN1084408A Cyclic adhesion inhibitors |
| 03/29/1994 | US5298621 Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same |
| 03/29/1994 | US5298612 Endonucleases |
| 03/29/1994 | US5298604 Parital primary amino acid sequence of the antineoplastic protein (ANUP); a cytokine present in granulocytes |
| 03/29/1994 | US5298603 Human granulocyte macrophage colony stimulating factor, expression in Escherichia bacteria |
| 03/29/1994 | US5298599 Fusion protein |
| 03/29/1994 | US5298596 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
| 03/29/1994 | US5298497 Method for preventing onset of hypertension employing a cholesterol lowering drug |
| 03/29/1994 | US5298493 Administering to the alimentary canal lactoserum, casein or casein minipeptide without phophopeptide |
| 03/29/1994 | US5298492 Inhibitors of endopeptidase and treatment of cardiovascular disorders |
| 03/29/1994 | US5298491 Analytical kit |
| 03/29/1994 | US5298490 Tetra and penta-peptides useful in regulating the immune system |
| 03/29/1994 | US5298489 DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI |
| 03/29/1994 | US5298488 Inhibiting cell adhesion and anticoagulants |
| 03/29/1994 | US5298422 Myogenic vector systems |
| 03/29/1994 | US5298420 Binds to peptide segment having thirteen amino acids |
| 03/29/1994 | US5298419 Diagnosis |
| 03/29/1994 | US5298402 Cell lines produced by transforming leukocytes of fish with oncogenes and physiologically active substances produced by the cell lines |
| 03/29/1994 | US5298400 Genetic engineering and gene expression |
| 03/29/1994 | US5298397 Reacting liqid phase with solid phase containg antibody, separation of phases, measuring bind antibody to solid phase |
| 03/29/1994 | US5298256 Desmopressin buccal patch composition |
| 03/29/1994 | US5298245 Bacillus thuringiensis isolates active against dipteran pests |
| 03/29/1994 | US5298243 Colony stimulating factor-gelatin conjugate |
| 03/29/1994 | US5298239 Mutations rendering platelet glycoprotein IB α less reactive |
| 03/29/1994 | US5298019 Controlled administration of chemodenervating pharmaceuticals |
| 03/26/1994 | CA2106629A1 Modified platelet factor-4 |
| 03/25/1994 | CA2106821A1 Glycosylated cytokines |
| 03/23/1994 | EP0588642A1 Kainate-binding, human CNS receptors of the EAA5 family |
| 03/23/1994 | EP0588477A2 Medicinal composition comprising TCF-II |
| 03/23/1994 | EP0588379A2 Treatment of wrinkling |
| 03/23/1994 | EP0588255A1 Physiologically active peptide compositions |
| 03/23/1994 | EP0588177A2 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
| 03/23/1994 | EP0588122A1 Improved antibodies to plasmodium falciparum |
| 03/23/1994 | EP0588118A2 Bone-related carboxypeptidase-like protein and process for its production |
| 03/23/1994 | EP0588036A2 Composition for isolating apamin receptors, apamin binding protein and uses thereof |
| 03/23/1994 | EP0587858A1 Protein formulation comprising growth hormone |
| 03/23/1994 | EP0587815A1 Hypertonic isochloremic formulation for circulatory shock |
| 03/23/1994 | EP0587806A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| 03/23/1994 | EP0587799A1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 03/23/1994 | EP0587797A1 Disinfecting shampoo composition for animals. |
| 03/23/1994 | EP0587777A1 Cea-binding proteins and methods for their isolation and use |
| 03/23/1994 | EP0587767A1 Hydroxyazido derivatives and related compounds as renin inhibitors |
| 03/23/1994 | EP0587754A1 Method for improving autologous transplantation |
| 03/23/1994 | EP0587751A1 Therapeutic compositions for osteoinduction |
| 03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
| 03/23/1994 | EP0587639A1 Pharmaceutical compositions |
| 03/23/1994 | EP0587636A1 Fish vaccine for aeromonas salmonicida infection |
| 03/23/1994 | EP0587610A1 Specifically beta-beta cross-linked hemoglobins and method of preparation |
| 03/23/1994 | EP0587590A1 Nerve growth factor for use in the prevention and treatment of viral infections |
| 03/23/1994 | EP0587571A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 03/23/1994 | EP0587555A1 A bifunctional dtpa-type ligand |
| 03/23/1994 | EP0458939B1 STABILIZATION OF t-PA pro |
| 03/23/1994 | EP0443047B1 Liquid nutrient composition |
| 03/23/1994 | EP0433360B1 Improvements relating to the production of prodrugs |
| 03/23/1994 | EP0362274B1 Treatment and diagnosis of footrot using the basic protease of bacteroides nodosus |
| 03/23/1994 | CN1084216A Method of intracellular binding of target molecules |
| 03/23/1994 | CN1084079A Ophthalmic compositions |
| 03/22/1994 | US5296608 Intermediates for analogs of tyrosine sulfate or tyrosine phosphate containing peptides |
| 03/22/1994 | US5296604 Proline derivatives and compositions for their use as inhibitors of HIV protease |
| 03/22/1994 | US5296591 Trifluoromethylketone derivatives, processes for preparation thereof and use thereof |
| 03/22/1994 | US5296509 Thioester enantiomeric compounds and their therapeutic uses |
| 03/22/1994 | US5296468 GnRH analogs |
| 03/22/1994 | US5296467 Polypeptide salts |
| 03/22/1994 | US5296466 Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
| 03/22/1994 | US5296465 Containing crosslinked hemoglobin in aqueous carrier medium |
| 03/22/1994 | US5296464 Promoting proliferation of useful microorganism by adding bovine lactoferrin to food containing said microorganisms |
| 03/22/1994 | US5296463 Compositions and methods for improving cold tolerance in animals and humans |
| 03/22/1994 | US5296368 Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 03/22/1994 | US5296366 Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant DNA and transformed microorgnaisms |
| 03/22/1994 | US5296353 Evaluation and treatment of patients with progessive immunosuppression |
| 03/22/1994 | US5296348 Selecting antibody specific for surface antigen on tumor cell |
| 03/22/1994 | US5296243 Including in feed sugars, sugar alcohols, amino acids or amides to produce lectins which attach to agarose in neutral buffer, dissociate after addition of methyl glucoside |
| 03/22/1994 | US5296231 Producing liposome encapsulated DNA repair enzyme |
| 03/22/1994 | US5296223 Subtilisin as an oral thrombolytic agent |
| 03/22/1994 | US5295944 Antitumor agents |
| 03/17/1994 | WO1994015625A1 Factor viii - polymeric conjugates |
| 03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | WO1994005801A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 03/17/1994 | WO1994005800A1 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005799A1 Sodium ion binding proteins |
| 03/17/1994 | WO1994005796A1 Long wap promoter for mammary expression of human protein c |
| 03/17/1994 | WO1994005794A1 DNA ENCODING THE HEME-REGULATED EUKARYOTIC INITIATION FACTOR 2α KINASE |
| 03/17/1994 | WO1994005791A2 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005790A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 03/17/1994 | WO1994005789A1 Glucagon receptors |
| 03/17/1994 | WO1994005788A1 Neurotrophic peptide |
| 03/17/1994 | WO1994005787A1 Glycopeptides, method of obtaining them and biological applications thereof |
| 03/17/1994 | WO1994005786A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |